ArticleCureus2026
Prevalence of Oropharyngeal Dysphagia in Adults With Type 2 Diabetes Mellitus.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Type 2 diabetes mellitus (T2DM) is a metabolic disease with high prevalence and multiple complications, including diabetic neuropathy, which can interfere with the swallowing process, causing dysphagia and increased morbidity and mortality. The Eating Assessment Tool-10 (EAT-10) questionnaire is a validated and sensitive tool for the clinical screening of dysphagia in asymptomatic population. Materials and methods This is a descriptive and prospective study that included 69 patients over the age of 18 diagnosed with T2DM, with no neurological or surgical history affecting swallowing. The validated Spanish version of the EAT-10 questionnaire was administered, considering dysphagia to be a score ≥3. Demographic variables, duration of diabetes, and treatment were recorded and analyzed using inferential and descriptive statistics with a significance level of p≤0.05. Results A total of 69 patients were involved in the study, 44 (63.8%) of whom were women. The mean age was 54.7 years and the average duration of T2DM was seven years. A prevalence of dysphagia was found in 16 patients (23.2%), with no significant difference between this diagnosis and the variables of age, sex, or duration of the disease (p≤0.05). The most frequently affected items on the EAT-10 were those related to effort when swallowing and a sensation of residue in the throat. Conclusion Nearly a quarter of the patients with T2DM evaluated showed signs consistent with oropharyngeal dysphagia. The results reinforce the value of the EAT-10 as a rapid, inexpensive, and noninvasive screening tool for detecting subclinical swallowing disorders in the diabetic population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.